Cytokinetics, Inc. (CYTK) Posts Q2 EPS Loss of $0.23, Well Below Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 62.33 -0.53 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.86 | 52 Week High | $13.18 | |||
| Open | $63.01 | 52 Week Low | $6.00 | |||
| Day High | $64.07 | P/E | N/A | |||
| Day Low | $61.94 | EPS | $-1.24 | |||
| Volume | 2,061,245 | |||||
